Research Article

Exploration in the Mechanism of Zhisou San for the Treatment of Cough Variant Asthma Based on Network Pharmacology

Table 1

Eight targets with the highest score from core targets and the binding ability with active compounds of Zhisou San in treating cough variant asthma by molecular docking.

Target proteinsSymbolCompoundHerbsBinding energy (kcal/mol)

β2 Adrenergic receptorβ2-ADR7-Methoxy-3-methyl-2,5-dihydroxy-9,10-dihydrophenanthreneBB−6.09
StigmasterolJJ; BB−7.44
Delta-type opioid receptorOPRD1MedicarpinGC−6.18
ShinpterocarpinGC−5.78
C-X-C motif chemokine 10CXCL10QuercetinJJ; ZW; GC−6.62
Muscarinic acetylcholine receptor M2CHRM22-OxostenineBB−7.99
Beta-sitosterolJJ; ZW; BB; BQ−7.68
BisdehydroneotuberostemonineBB−7.97
DidehydrotuberostemonineBB−8.27
KaempferolZW; GC−6.88
MedicarpinGC−6.79
QuercetinJJ; ZW; GC−5.19
Sessilifoline BBB−7.15
Stemoninine BBB−8.69
StigmasterolJJ; BB−7.19
Tuberostemonine CBB−7.02
D1 dopamine receptorDRD1BisdehydroneotuberostemonineBB−9.38
Prostaglandin E2 receptor EP3 subtypePTGER3luteolinJJ; ZW; JG−5.92
QuercetinJJ; ZW; GC−5.12
Mu-type opioid receptorOPRM17-Methoxy-2-methyl isoflavoneGC−5.77
7-Methoxy-3-methyl-2,5-dihydroxy-9,10-dihydrophenanthreneBB−6.0
Beta-sitosterolJJ; ZW; BB; BQ−7.35
BisdehydroneotuberostemonineBB−7.35
DidehydrotuberostemonineBB−7.52
InermineGC−6.32
MedicarpinGC−5.74
QuercetinJJ; ZW; GC−5.03
ShinpterocarpinGC−6.97
Tuberostemonine CBB−7.26
Intercellular adhesion molecule 1ICAM1KaempferolZW; GC−6.36
LuteolinJJ; ZW; JG−6.66
QuercetinJJ; ZW; GC−6.46